Day at the Registry: Naloxone company lobbies for wider use of nasal spray
Photo via Adapt Pharma Canada Ltd.
Adapt Pharma Canada Ltd. has registered to lobby the federal government to encourage wider use of its naloxone spray, which can reverse opioid overdoses.
This content is available to lobbymonitor.ca subscribers.
Already a subscriber?
Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
